NASDAQ · COCH
Envoy Medical, Inc.
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
Loading market information…
NASDAQ · ADGM · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Adagio Medical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Adagio Medical Holdings, Inc.’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of -$0.25. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Adagio Medical Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
$0.77-$0.03 (-3.15%)
Leap Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.5% below the high.
$6.75-$0.44 (-6.12%)
Athira Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.26% below the high.
$0.56+$0.02 (+4.07%)
Citius Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.45% below the high.
$0.72-$0.02 (-2.92%)
IRIDEX Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.12% below the high.
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
$0.40-$0.05 (-10.49%)
Co-Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.41% below the high.
$0.12-$0.00 (-1.07%)
Vivos Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.57% below the high.
